Clinical Trial Update: Cranial Radiotherapy Plus Chemoimmunotherapy in Untreated Driver-mutation Negative NSCLC With Active Brain Metastasis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial from Fudan University evaluates cranial radiotherapy combined with chemoimmunotherapy for untreated driver-mutation negative non-small …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Non-small Cell Lung Cancer

Snippet

Sponsor: Fudan University | Conditions: NSCLC Stage IV | Phase 2 | Status: RECRUITING